Trials / Completed
CompletedNCT05327374
Use of ΔIVC for Early Diagnosis of AHF in AECOPD
Diagnosis of Acute Heart Failure in Chronic Obstructive Pulmonary Disease Exacerbation Using the Inferior Vena Cava Collapsibilty Index
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 401 (actual)
- Sponsor
- University of Monastir · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.
Detailed description
Acute heart failure (AHF) is a common cause of COPD exacerbation however its role is very often underestimated. Until now, the use of echocardiography and some invasive hemodynamic exploration techniques such as the Swanganz catheter has been stated as reference. Other noninvasive diagnostic methods have been studied, such as systolic time intervals and Valsalva maneuver, but their application still difficult in patients with COPD exacerbation, especially in emergency department (ED) settings. the study aimed to evaluate the performance of a new diagnostic technique based on the measurement of the ΔIVC for the early identification of AHF in patients presenting to the ED with acute COPD exacerbation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | calculation of the inferior vena cava collapsibility index | the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-11-30
- Completion
- 2023-01-31
- First posted
- 2022-04-14
- Last updated
- 2023-05-16
Locations
3 sites across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT05327374. Inclusion in this directory is not an endorsement.